These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 19038430

  • 1. Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort.
    Tareen B, Sankin A, Godoy G, Temkin S, Lepor H, Taneja SS.
    Urology; 2009 Feb; 73(2):351-4; discussion 354-5. PubMed ID: 19038430
    [Abstract] [Full Text] [Related]

  • 2. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer.
    Mouraviev V, Mayes JM, Sun L, Madden JF, Moul JW, Polascik TJ.
    Cancer; 2007 Aug 15; 110(4):906-10. PubMed ID: 17587207
    [Abstract] [Full Text] [Related]

  • 3. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?
    Tareen B, Godoy G, Sankin A, Temkin S, Lepor H, Taneja SS.
    BJU Int; 2009 Jul 15; 104(2):195-9. PubMed ID: 19191784
    [Abstract] [Full Text] [Related]

  • 4. Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy.
    Polascik TJ, Mayes JM, Sun L, Madden JF, Moul JW, Mouraviev V.
    Prostate; 2008 Sep 15; 68(13):1380-6. PubMed ID: 18543281
    [Abstract] [Full Text] [Related]

  • 5. Laterality alone should not drive selection of candidates for hemi-ablative focal therapy.
    Tareen B, Godoy G, Sankin A, Temkin S, Lepor H, Taneja SS.
    J Urol; 2009 Mar 15; 181(3):1082-9; discussion 1089-90. PubMed ID: 19150090
    [Abstract] [Full Text] [Related]

  • 6. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.
    Sankin A, Tareen B, Lepor H.
    Prostate Cancer Prostatic Dis; 2009 Mar 15; 12(2):204-8. PubMed ID: 19238170
    [Abstract] [Full Text] [Related]

  • 7. Influence of nerve-sparing (NS) procedure during radical prostatectomy (RP) on margin status and biochemical failure.
    Palisaar RJ, Noldus J, Graefen M, Erbersdobler A, Haese A, Huland H.
    Eur Urol; 2005 Feb 15; 47(2):176-84. PubMed ID: 15661411
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients.
    Zlotta AR, Roumeguère T, Ravery V, Hoffmann P, Montorsi F, Türkeri L, Dobrovrits M, Scattoni V, Ekane S, Bollens R, Vanden Bossche M, Djavan B, Boccon-Gibod L, Schulman CC, European Society for Urological Oncology.
    Eur Urol; 2004 Jul 15; 46(1):42-9. PubMed ID: 15183546
    [Abstract] [Full Text] [Related]

  • 10. Prostate cancer laterality does not predict prostate-specific antigen recurrence after radical prostatectomy.
    Mouraviev V, Sun L, Madden JF, Mayes JM, Moul JW, Polascik TJ.
    Urology; 2007 Dec 15; 70(6):1141-5. PubMed ID: 18158035
    [Abstract] [Full Text] [Related]

  • 11. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database.
    Scales CD, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL, Freedland SJ, SEARCH Database Study Group.
    J Urol; 2007 Oct 15; 178(4 Pt 1):1249-52. PubMed ID: 17698131
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy.
    Schroeck FR, Sun L, Freedland SJ, Jayachandran J, Robertson CN, Moul JW.
    Prostate Cancer Prostatic Dis; 2008 Oct 15; 11(4):371-6. PubMed ID: 18427570
    [Abstract] [Full Text] [Related]

  • 14. Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience.
    Xylinas E, Drouin SJ, Comperat E, Vaessen C, Renard-Penna R, Misrai V, Bitker MO, Chartier-Kastler E, Richard F, Cussenot O, Roupret M.
    BJU Int; 2009 May 15; 103(9):1173-8; discussion 1178. PubMed ID: 19040530
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of a tertiary Gleason grade and its impact on adverse histopathologic parameters in a contemporary radical prostatectomy series.
    Isbarn H, Ahyai SA, Chun FK, Budäus L, Schlomm T, Salomon G, Zacharias M, Erbersdobler A, Köllermann J, Sauter G, Huland H, Graefen M, Steuber T.
    Eur Urol; 2009 Feb 15; 55(2):394-401. PubMed ID: 18718699
    [Abstract] [Full Text] [Related]

  • 16. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.
    Moussa AS, Li J, Soriano M, Klein EA, Dong F, Jones JS.
    BJU Int; 2009 Jan 15; 103(1):43-8. PubMed ID: 18782303
    [Abstract] [Full Text] [Related]

  • 17. Perineural invasion is a prognostic factor for biochemical failure after radical prostatectomy.
    Jeon HG, Bae J, Yi JS, Hwang IS, Lee SE, Lee E.
    Int J Urol; 2009 Aug 15; 16(8):682-6. PubMed ID: 19602004
    [Abstract] [Full Text] [Related]

  • 18. A pretreatment table for the prediction of final histopathology after radical prostatectomy in clinical unilateral T3a prostate cancer.
    Joniau S, Hsu CY, Lerut E, Van Baelen A, Haustermans K, Roskams T, Oyen R, Van Poppel H.
    Eur Urol; 2007 Feb 15; 51(2):388-94; discussion 395-6. PubMed ID: 16901622
    [Abstract] [Full Text] [Related]

  • 19. Robot-assisted laparoscopic prostatectomy is not associated with early postoperative radiation therapy.
    Chino J, Schroeck FR, Sun L, Lee WR, Albala DM, Moul JW, Koontz BF.
    BJU Int; 2009 Nov 15; 104(10):1496-500. PubMed ID: 19388991
    [Abstract] [Full Text] [Related]

  • 20. Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes?
    Caire AA, Sun L, Ode O, Stackhouse DA, Maloney K, Donatucci C, Mouraviev V, Polascik TJ, Robertson CN, Albala DM, Moul JW.
    Urology; 2009 Sep 15; 74(3):643-7. PubMed ID: 19501891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.